Profil
Mark-Andre Freyberg is the founder of Dermatools Biotech GmbH (founded in 2004), Cytopharma GmbH (founded in 2006), and bioXXmed AG (founded in 2000).
At bioXXmed AG, he held the title of Chief Executive Officer from 2000 to 2021.
Dr. Freyberg's former jobs include Chief Executive Officer at TemplaTech GmbH and Project Manager at Technische Universität Darmstadt.
He earned a doctorate degree from Technische Universität Darmstadt.
Tidigare kända positioner av Mark-Andre Freyberg
| Företag | Position | Slut |
|---|---|---|
| BIOXXMED AG | Verkställande Direktör | 2021-09-30 |
TemplaTech GmbH
TemplaTech GmbH BiotechnologyHealth Technology Develops biological medical products | President | 2007-09-03 |
Dermatools Biotech GmbH
Dermatools Biotech GmbH Miscellaneous Commercial ServicesCommercial Services Engages in research and development in the field of natural sciences, engineering, agricultural sciences and medicine | Grundare | - |
Cytopharma GmbH | Grundare | - |
Technische Universität Darmstadt
Technische Universität Darmstadt Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Mark-Andre Freybergs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Technische Universität Darmstadt
Technische Universität Darmstadt Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
bioXXmed AG
bioXXmed AG Pharmaceuticals: MajorHealth Technology Manufactures active ingredients | Health Technology |
TemplaTech GmbH
TemplaTech GmbH BiotechnologyHealth Technology Develops biological medical products | Health Technology |
Dermatools Biotech GmbH
Dermatools Biotech GmbH Miscellaneous Commercial ServicesCommercial Services Engages in research and development in the field of natural sciences, engineering, agricultural sciences and medicine | Commercial Services |
Cytopharma GmbH |
















